2 studies found for:    21208106 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Rifaximin 3 Times/Day for Non-constipation IBS
Condition: Non-constipation Irritable Bowel Syndrome
Interventions: Drug: Rifaximin;   Drug: Placebo
2 Completed Rifaximin TID for Non-constipation Irritable Bowel Syndrome (IBS)
Condition: Non-constipation Irritable Bowel Syndrome
Interventions: Drug: Rifaximin;   Drug: Placebo

Indicates status has not been verified in more than two years